Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model

There is a significant clinical need for effective therapies for primary progressive multiple sclerosis, which presents later in life (i.e., older than 50 years) and has symptoms that increase in severity without remission. With autologous mesenchymal stem cell therapy now in the early phases of cli...

詳細記述

保存先:
書誌詳細
主要な著者: Scruggs, Brittni A., Semon, Julie A., Zhang, Xiujuan, Zhang, Shijia, Bowles, Annie C., Pandey, Amitabh C., Imhof, Kathleen M.P., Kalueff, Allan V., Gimble, Jeffrey M., Bunnell, Bruce A.
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2013
主題:
Tissue Engineering and Regenerative Medicine
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785264/
https://ncbi.nlm.nih.gov/pubmed/24018793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0026
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料